Summary by Moomoo AI
Lloyd Carney, associated with Vertex Pharmaceuticals Inc. [VRTX], was granted 1,001 shares of common stock on May 1, 2024. The transaction, which was completed on the same date, was a grant with a transaction price of $0.00 per share, indicating that the shares were likely awarded as part of a compensation package or incentive plan. Following this transaction, Carney's direct holdings in Vertex Pharmaceuticals common stock increased to a total of 6,319 shares. The grant is part of the company's ongoing efforts to align the interests of its executives with those of its shareholders.